Never know common, anything is possible! this is a huge step forward strategically for the company that will have very large scale implications down the line. Remains to be seen if there is any impact on SP, but for me personally this is a huge PR that I have been anticipating regardless of whether SP is impacted or not in the short term.

It is just mind boggling to know we will now have several trials and studies spanning across the country and across the globe putting Kevetrin through its paces. Leo is doing a PHENOMENAL job managing these relationships and securing commitments from the finest cancer institutions in the world.

Simply awesome.

And oh, by the way, we are looking ready to hit triple digits in dosage at DF. We are well on our way now.